Data / Drug companies / Tramadol hydrochloride
Tramadol hydrochloride: 44 companies and 119 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Tramadol hydrochloride is listed in the FDA National Drug Code Directory by 44 companies, with 119 products in commercial distribution. 112 of the products (94.1%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, extended release; tablet, coated; tablet, and the newest product started marketing on November 3, 2026.
The request: Get every company that lists tramadol hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 44
- Products
- 119
- Generic (ANDA) products
- 112 (94.1%)
- Application numbers
- 14
- Controlled substance schedule
- Schedule IV
- Routes
- Oral
- Brand names
- ConZip
- openFDA record search
- api.fda.gov
Companies that list tramadol hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Asclemed USA, Inc. | 9 | tablet, extended release; tablet, coated | Generic drugs (ANDA) | November 28, 2023 |
| Bryant Ranch Prepack | 8 | tablet; tablet, extended release | Generic drugs (ANDA) | August 5, 2024 |
| Lupin Pharmaceuticals, Inc. | 6 | tablet, extended release | Generic drugs (ANDA) | August 19, 2014 |
| Preferred Pharmaceuticals Inc. | 6 | tablet, extended release; tablet, film coated | Generic drugs (ANDA) | June 8, 2026 |
| Proficient Rx LP | 6 | tablet, extended release; tablet, film coated | Generic drugs (ANDA) | September 23, 2020 |
| Remedyrepack Inc. | 6 | tablet, extended release; tablet, coated | Generic drugs (ANDA) | November 3, 2026 |
| Sun Pharmaceutical Industries, Inc. | 6 | tablet, extended release | Generic drugs (ANDA) | December 30, 2011 |
| Advanced Rx of Tennessee, LLC | 5 | tablet, coated; tablet | Generic drugs (ANDA) | June 26, 2026 |
| NuCare Pharmaceuticals,Inc. | 5 | tablet, extended release; tablet | Generic drugs (ANDA) | March 1, 2018 |
| Advagen Pharma Ltd | 4 | tablet, coated | Generic drugs (ANDA) | November 28, 2023 |
| A-S Medication Solutions | 3 | tablet, film coated; tablet, extended release | Generic drugs (ANDA) | August 9, 2019 |
| Bryant Ranch Prepack | 3 | tablet, extended release | Generic drugs (ANDA) | August 19, 2014 |
| Coupler LLC | 3 | tablet, coated; tablet, extended release | Generic drugs (ANDA) | June 22, 2026 |
| Macleods Pharmaceuticals Limited | 3 | tablet, film coated, extended release | Generic drugs (ANDA) | January 31, 2025 |
| Proficient Rx LP | 3 | tablet, film coated, extended release; tablet | Generic drugs (ANDA) | January 31, 2025 |
| Rising Pharma Holdings, Inc. | 3 | tablet | Generic drugs (ANDA) | October 15, 2026 |
| Trigen Laboratories, LLC | 3 | capsule | Authorized generics (NDA) | June 22, 2015 |
| TruPharma, LLC | 3 | tablet, coated; solution | Generic drugs (ANDA) | September 11, 2020 |
| Vertical Pharmaceuticals, LLC | 3 | capsule, extended release | New drug applications (NDA) | September 20, 2011 |
| Direct_Rx | 2 | tablet, coated; tablet, extended release | Generic drugs (ANDA) | January 12, 2022 |
| Northwind Health Company, LLC | 2 | tablet, coated; tablet | Generic drugs (ANDA) | June 25, 2026 |
| Proficient Rx LP | 2 | tablet, coated; tablet, extended release | Generic drugs (ANDA) | December 12, 2011 |
| Quality Care Products, LLC | 2 | tablet, coated; tablet, extended release | Generic drugs (ANDA) | February 7, 2023 |
| St. Mary's Medical Park Pharmacy | 2 | tablet, film coated; tablet | Generic drugs (ANDA) | November 5, 2025 |
| Strides Pharma Science Limited | 2 | tablet | Generic drugs (ANDA) | September 1, 2026 |
| American Health Packaging | 1 | tablet, coated | Generic drugs (ANDA) | January 20, 2024 |
| Amneal Pharmaceuticals LLC | 1 | tablet, coated | Generic drugs (ANDA) | November 15, 2010 |
| Amneal Pharmaceuticals NY LLC | 1 | tablet, coated | Generic drugs (ANDA) | February 13, 2023 |
| Amneal Pharmaceuticals NY LLC | 1 | tablet, coated | Generic drugs (ANDA) | November 15, 2010 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | June 19, 2002 |
| Asclemed USA Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | August 9, 2019 |
| Aurobindo Pharma Limited | 1 | tablet, film coated | Generic drugs (ANDA) | September 23, 2020 |
| Clinical Solutions Wholesale, LLC | 1 | tablet, coated | Generic drugs (ANDA) | February 13, 2023 |
| Cranbury Pharmaceuticals, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | December 22, 2024 |
| Direct RX | 1 | tablet, extended release | Generic drugs (ANDA) | January 1, 2014 |
| Golden State Medical Supply, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | June 19, 2002 |
| Major Pharmaceuticals | 1 | tablet, coated | Generic drugs (ANDA) | November 22, 2024 |
| Medsource Pharmaceuticals | 1 | tablet, extended release | Generic drugs (ANDA) | August 19, 2014 |
| Quality Care Products, LLC | 1 | tablet, extended release | Generic drugs (ANDA) | March 3, 2023 |
| Redpharm Drug | 1 | tablet, coated | Generic drugs (ANDA) | April 22, 2021 |
| Rising Pharma Holdings, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | September 23, 2020 |
| Teva Pharmaceuticals USA, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | September 12, 2024 |
| Unichem Pharmaceuticals (USA), Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | August 9, 2019 |
| Unit Dose Solutions, Inc. | 1 | tablet, coated | Generic drugs (ANDA) | September 23, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, extended release | 44 | 37% |
| Tablet, coated | 33 | 27.7% |
| Tablet | 16 | 13.4% |
| Tablet, film coated | 15 | 12.6% |
| Tablet, film coated, extended release | 4 | 3.4% |
| Capsule | 3 | 2.5% |
| Capsule, extended release | 3 | 2.5% |
| Solution | 1 | 0.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 112 | 94.1% |
| Authorized generics (NDA) | 4 | 3.4% |
| New drug applications (NDA) | 3 | 2.5% |
Pharmacologic classes
| Class | Products |
|---|---|
| Opioid Agonist | 119 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.